Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study
Titel:
Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study
Auteur:
Tabernero, J. Ciardiello, F. Rivera, F. Rodriguez-Braun, E. Ramos, F.J. Martinelli, E. Vega-Villegas, M.E. Roselló, S. Liebscher, S. Kisker, O. Macarulla, T. Baselga, J. Cervantes, A.